Cargando…

The ability of early changes in motivation to predict later antidepressant treatment response

INTRODUCTION: Baseline values and early changes of emotional reactivity, cognitive speed, psychomotor function, motivation, and sensory perception have not been studied to any extent in unipolar depression, although they could help to characterize different dimensions of illness that are harder to c...

Descripción completa

Detalles Bibliográficos
Autores principales: Gorwood, Philip, Vaiva, Guillaume, Corruble, Emmanuelle, Llorca, Pierre-Michel, Baylé, Franck J, Courtet, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646593/
https://www.ncbi.nlm.nih.gov/pubmed/26635476
http://dx.doi.org/10.2147/NDT.S92795
_version_ 1782400957545447424
author Gorwood, Philip
Vaiva, Guillaume
Corruble, Emmanuelle
Llorca, Pierre-Michel
Baylé, Franck J
Courtet, Philippe
author_facet Gorwood, Philip
Vaiva, Guillaume
Corruble, Emmanuelle
Llorca, Pierre-Michel
Baylé, Franck J
Courtet, Philippe
author_sort Gorwood, Philip
collection PubMed
description INTRODUCTION: Baseline values and early changes of emotional reactivity, cognitive speed, psychomotor function, motivation, and sensory perception have not been studied to any extent in unipolar depression, although they could help to characterize different dimensions of illness that are harder to capture by clinicians, give new insights on how patients improve, and offer new early clinical markers for later treatment response. METHODS: About 1,565 adult outpatients with major depressive disorder receiving agomelatine completed the clinician-rated 16-item quick inventory of depressive symptoms, Clinical Global Impression, and Multidimensional Assessment of Thymic States (MAThyS) rating scales at inclusion, Week 2 and Week 6. The MAThyS includes a 20-item self-rated visual analog scale (from inhibition [0] to activation [10], with [5] representing the usual state) leading to five a priori dimensions (emotional reactivity, cognitive speed, psychomotor function, motivation, and sensory perception). RESULTS: All MAThyS dimension scores increased from inclusion to Week 2 and from inclusion to Week 6 (P<0.001). Improvement was around 2 points (out of 10) for motivation, 1.5 points for psychomotor function, and 0.5 points for other dimensions. Motivation showed a trend to being more severely impaired at inclusion in future nonresponders (t=1.25, df=1,563, P=0.10). Its improvement at Week 2 was the most discriminating MAThyS dimension between future responders and nonresponders, and represents the best predictor of future response, with the highest area under the receptor operating characteristic curve (area under curve =0.616, 95% confidence interval [0.588–0.643], P<0.001). Finally, improvements in motivation correlated the most strongly with clinician-rated 16-item quick inventory of depressive symptoms improvement (r=−0.491, df=1,563, P<0.001). CONCLUSION: Motivation had the most capacity for early improvement, the best predictive value for response, and the largest global margin of progress in depressed outpatients. Assessing the evolution of self-reported motivation over time in major depressive disorder could offer an interesting complementary approach to predict response.
format Online
Article
Text
id pubmed-4646593
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-46465932015-12-03 The ability of early changes in motivation to predict later antidepressant treatment response Gorwood, Philip Vaiva, Guillaume Corruble, Emmanuelle Llorca, Pierre-Michel Baylé, Franck J Courtet, Philippe Neuropsychiatr Dis Treat Original Research INTRODUCTION: Baseline values and early changes of emotional reactivity, cognitive speed, psychomotor function, motivation, and sensory perception have not been studied to any extent in unipolar depression, although they could help to characterize different dimensions of illness that are harder to capture by clinicians, give new insights on how patients improve, and offer new early clinical markers for later treatment response. METHODS: About 1,565 adult outpatients with major depressive disorder receiving agomelatine completed the clinician-rated 16-item quick inventory of depressive symptoms, Clinical Global Impression, and Multidimensional Assessment of Thymic States (MAThyS) rating scales at inclusion, Week 2 and Week 6. The MAThyS includes a 20-item self-rated visual analog scale (from inhibition [0] to activation [10], with [5] representing the usual state) leading to five a priori dimensions (emotional reactivity, cognitive speed, psychomotor function, motivation, and sensory perception). RESULTS: All MAThyS dimension scores increased from inclusion to Week 2 and from inclusion to Week 6 (P<0.001). Improvement was around 2 points (out of 10) for motivation, 1.5 points for psychomotor function, and 0.5 points for other dimensions. Motivation showed a trend to being more severely impaired at inclusion in future nonresponders (t=1.25, df=1,563, P=0.10). Its improvement at Week 2 was the most discriminating MAThyS dimension between future responders and nonresponders, and represents the best predictor of future response, with the highest area under the receptor operating characteristic curve (area under curve =0.616, 95% confidence interval [0.588–0.643], P<0.001). Finally, improvements in motivation correlated the most strongly with clinician-rated 16-item quick inventory of depressive symptoms improvement (r=−0.491, df=1,563, P<0.001). CONCLUSION: Motivation had the most capacity for early improvement, the best predictive value for response, and the largest global margin of progress in depressed outpatients. Assessing the evolution of self-reported motivation over time in major depressive disorder could offer an interesting complementary approach to predict response. Dove Medical Press 2015-11-11 /pmc/articles/PMC4646593/ /pubmed/26635476 http://dx.doi.org/10.2147/NDT.S92795 Text en © 2015 Gorwood et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Gorwood, Philip
Vaiva, Guillaume
Corruble, Emmanuelle
Llorca, Pierre-Michel
Baylé, Franck J
Courtet, Philippe
The ability of early changes in motivation to predict later antidepressant treatment response
title The ability of early changes in motivation to predict later antidepressant treatment response
title_full The ability of early changes in motivation to predict later antidepressant treatment response
title_fullStr The ability of early changes in motivation to predict later antidepressant treatment response
title_full_unstemmed The ability of early changes in motivation to predict later antidepressant treatment response
title_short The ability of early changes in motivation to predict later antidepressant treatment response
title_sort ability of early changes in motivation to predict later antidepressant treatment response
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646593/
https://www.ncbi.nlm.nih.gov/pubmed/26635476
http://dx.doi.org/10.2147/NDT.S92795
work_keys_str_mv AT gorwoodphilip theabilityofearlychangesinmotivationtopredictlaterantidepressanttreatmentresponse
AT vaivaguillaume theabilityofearlychangesinmotivationtopredictlaterantidepressanttreatmentresponse
AT corrubleemmanuelle theabilityofearlychangesinmotivationtopredictlaterantidepressanttreatmentresponse
AT llorcapierremichel theabilityofearlychangesinmotivationtopredictlaterantidepressanttreatmentresponse
AT baylefranckj theabilityofearlychangesinmotivationtopredictlaterantidepressanttreatmentresponse
AT courtetphilippe theabilityofearlychangesinmotivationtopredictlaterantidepressanttreatmentresponse
AT gorwoodphilip abilityofearlychangesinmotivationtopredictlaterantidepressanttreatmentresponse
AT vaivaguillaume abilityofearlychangesinmotivationtopredictlaterantidepressanttreatmentresponse
AT corrubleemmanuelle abilityofearlychangesinmotivationtopredictlaterantidepressanttreatmentresponse
AT llorcapierremichel abilityofearlychangesinmotivationtopredictlaterantidepressanttreatmentresponse
AT baylefranckj abilityofearlychangesinmotivationtopredictlaterantidepressanttreatmentresponse
AT courtetphilippe abilityofearlychangesinmotivationtopredictlaterantidepressanttreatmentresponse